Related Experiment Video
Updated: May 6, 2026

08:22
Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria
Published on: May 16, 2025
655
Copper-induced immunotoxicity involves cell cycle arrest and cell death in the liver
Tarun Keswani1, Soham Mitra, Arindam Bhattacharyya
1Immunology Laboratory, Department of Zoology, University of Calcutta, 35, Ballygunge Circular Road, Kolkata, 700019, West Bengal, India.
Environmental Toxicology
|October 31, 2013
Summary
Inorganic copper exposure induces liver cell death through apoptosis, a process independent of p53. This study reveals copper
Area of Science:
- Hepatology
- Immunotoxicology
- Cellular Biology
Background:
- Inorganic copper bypasses the liver, entering the blood's free copper pool.
- Copper exposure is linked to immunosuppression and liver toxicity.
Purpose of the Study:
- Investigate the mechanisms of copper-induced apoptosis in liver cells.
- Elucidate copper's regulation of apoptotic pathways and its role in immunosuppression.
Main Methods:
- Western blotting and immunohistochemistry for protein expression analysis.
- Flow cytometry to assess mitochondrial membrane potential, Annexin V binding, ROS generation, and cell cycle.
- Histomorphological analysis of liver tissues.
Main Results:
- Copper treatment caused dose-related liver histomorphological changes and immunotoxicity.
- Increased hepatocyte apoptosis was confirmed by Sub-G0/G1 phase increase and Annexin V assay.
- Copper altered apoptotic marker expression, increased ROS, and disrupted mitochondrial potential, activating a p53-independent intrinsic apoptosis pathway.
- The p73 molecule was identified as a key player in copper-induced apoptosis.
Conclusions:
- Copper induces apoptosis in liver cells via a p53-independent intrinsic pathway.
- Apoptotic pathways significantly contribute to copper-induced immunosuppression in the liver.
- p73 plays a crucial role in mediating copper's apoptotic effects in hepatocytes.
Related Concept Videos
Drug Toxicity: Dose-Dependent Reactions
245
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
245
Drug Toxicity: Allergic Reactions
223
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
223
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
386
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
386

